Welcome to the e-CCO Library Archive!
P671
Pregnancy and IBD, do we provide enough patient education? A British study of 1 324 women
I. Carbery, C. Selinger*
St James University Hospital, Gastroenterology, Leeds, United Kingdom
P672
Eosinophilia of the gut: Is it inflammatory bowel disease?
S. Chetcuti Zammit*1, J. Gauci2, M. Cachia2, K. Sapiano2, P. Ellul1
1Mater Dei Hospital, Gastroenterology, Msida, Malta, 2Mater Dei Hospital, Medicine, Msida, Malta
P673
A model of inflammatory bowel disease (IBD) population-based registry; incidence of IBD in the Romagna region
D. Valpiani1, I. Manzi*1, L. Samperi1, S. Gasperoni2, O. Triossi2, M. Di Marco3, A. De Padova3, L. Solmi3, C. Bernabini4, O. Giuliani5, S. Giorgetti5, F. Falcini5, E. Ricci1
1AUSL Romagna, presidio di Forli’, Gastroenterologia ed Endoscopia Digestiva, Forli’, Italy, 2AUSL Romagna, presidio di Ravenna, Gastroenterologia ed Endoscopia Digestiva, Ravenna, Italy, 3AUSL Romagna, presidio di Rimini, Gastroenterologia ed Endoscopia Digestiva, Rimini, Italy, 4AUSL Romagna, presidio di Cesena, Gastroenterologia ed Endoscopia Digestiva, Cesena, Italy, 5Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Registro Tumori della Romagna, Meldola, Italy
P674
Clinical features of thrombosis in patients with Crohn’s disease followed at the Clinical Hospital of the University of São Paulo, Brazil
A. Ribas Andrade, L. Leite Barros, M. Azevedo, A. Sipahi, A. Zonetti de Arruda Leite*
University of São Paulo, Medical School, Department of Gastroenterology, São Paulo, Brazil
P675
Clinical characteristics of Crohn’s disease and ulcerative colitis patients who switched from an anti-TNF-α agent or natalizumab to vedolizumab or an alternative anti-TNF-α
H. Liang1, S. Manne1, J. Shick1, S. Yu1, G. Fusco1, P. Dolin*2
1Takeda Development Centre Americas, Inc., Deerfield, United States, 2Takeda Development Centre Europe Ltd., London, United Kingdom
P676
Influence of hypoxia on healthy volunteers and patients with inflammatory bowel disease
S. Vavricka*1, 2, P. Ruiz-Castro1, L. Biedermann1, M. Madanchi1, S. Scharl1, M. Scharl1, G. Rogler1, J. Zeitz1
1University Hospital Zurich, Department of Gastroenterology and Hepatology, Zurich, Switzerland, 2Triemli Hospital, Division of Gastroenterology and Hepatology, Zurich, Switzerland
P677
Use and predictors of complementary and alternative medicine in patients with inflammatory bowel disease: results of a multicentre study of the Austrian IBD Study Group (ATISG)
H. P. Gröchenig*1, C. Dejaco2, G. Eckhard3, T. Feichtenschlager4, T. Haas5, A. Kirchgatterer6, R. Koch7, O. Ludwiczek8, A. Mayer9, W. Miehsler10, P. Papay11, P.-G. Peters12, R. Platzer13, G. Reicht14, P. Steiner15, T. Waldhör16, H. Wenzl17, H. Fuchssteiner18, J. Gartner19, G. Novacek2
1Krankenhaus Barmherzige Brüder, Innere Medizin, St Veit an der Glan, Austria, 2Medizinische Universität Wien, Universitätsklinik für Innere Medizin III, Vienna, Austria, 3Landeskrankenhaus Oberpullendorf, Interne Abteilung, Oberpullendorf, Austria, 4Krankenhaus Rudolfstiftung Wien, IV Medizinische Abteilung, Wien, Austria, 5Darmpraxis Salzburg, Ordination, Salzburg, Austria, 6Klinikum Wels-Grieskirchen, Abteilung für Innere Medizin V, Grieskirchen, Austria, 7Medizinische Universität Innsbruck, Innere Medizin I, Innsbruck, Austria, 8Landeskrankenhaus Hall in Tirol, Innere Medizin, Hall in Tirol, Austria, 9Universitätsklinikum St. Pölten, 2. Medizinische Abteilung, St. Pölten, Austria, 10Krankenhaus Barmherzige Brüder, Innere Medizin, Salzburg, Austria, 11Hartmannspital Wien, Innere Medizin, Wien, Austria, 12Landeskrankenhaus Feldkirch, Abteilung für Innere Medizin, Feldkirch, Austria, 13Landeskrankenhaus Wiener Neustadt, Abteilung für Innere Medizin I, Wiener Neustadt, Austria, 14Krankenhaus Barmherzige Brüder Graz, Abteilung für Innere Medizin, Graz, Austria, 15Klinikum Wels-Grieskirchen, Abteilung für Innere Medizin I, Wels, Austria, 16Medizinische Universität Wien, Abteilung für Epidemiologie, Wien, Austria, 17Medizinische Universität Graz, Abteilung für Gastroenterologie & Hepatologie, Graz, Austria, 18KH Elisabethinen Linz, Innere Medizin IV, Linz, Austria, 19Hanusch Krankenhaus, Innere Medizin, Wien, Austria
P678
Factors associated with voluntary childlessness in women with inflammatory bowel disease
C. Selinger*1, J. Ghorayeb2, A. Madill2
1St James University Hospital, Gastroenterology, Leeds, United Kingdom, 2University of Leeds, School of Psychology, Leeds, United Kingdom
P679
Mental health is associated with disease course in a sub-group of inflammatory disease bowel patients with Crohn’s disease and ulcerative colitis: a multicentre observational study by the Osaka Gut Forum
M. Araki*1, S. Shinzaki1, H. Iijima1, S. Hiyama1, T. Yamada2, S. Arimitsu3, M. Komori4, N. Shibukawa5, A. Mukai6, S. Nakajima7, K. Kinoshita8, T. Miyagi9, S. Kitamura10, Y. Murayama11, H. Ogawa12, Y. Yasunaga13, M. Oshita14, E. Masuda15, H. Tanimukai16, M. Tsujii1, 4, T. Takehara1
1Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology, 2-2 Yamadaoka, Suita, Japan, 2Osaka Medical Centre, National Hospital Organisation, Department of Gastroenterology, 2-1-14, Hoenzaka, Chuo-ku, Osaka, Japan, 3Kinshukai, Infusion Clinic, Osaka, Japan, 4Osaka Rosai Hospital, Department of Gastroenterology, 1179-3, Nagasone-cho, Kita-ku, Sakai, Osaka, Japan, 5NTT-west Hospital, Department of Gastroenterology, 2-6-40, Karasugatsuji, Tennoji-ku, Osaka, Japan, 6Sumitomo Hospital, Department of Gastroenterology, 5-3-20, Nakanoshima, Kita-ku, Osaka, Japan, 7Toyonaka Municipal Hospital, Department of Gastroenterology, 4-14-1, Shibahara-cho, Toyonaka, Osaka, Japan, 8Otemae Hospital, Department of Gastroenterology, 1-5-34, Otemae, Chuo-ku, Osaka, Japan, 9Yao Municipal Hospital, Department of Gastroenterology, 1-3-1, Ryukacho, Yao, Osaka, Japan, 10Sakai City Hospital, Department of Gastroenterology, 1-1-1, Minamiyasui-cho, Sakai-ku, Sakai, Osaka, Japan, 11Itami City Hospital, Department of Gastroenterology, 1–100, Koyaike, Itami, Hyogo, Japan, 12Nishinomiya Municipal Central Hospital, Department of Gastroenterology, 8–24, Hayashida-cho, Nishinomiya, Hyogo, Japan, 13Hyogo Prefectural Nishinomiya Hospital, Department of Gastroenterology, 13–9, Rokutanji-cho, Nishinomiya, Hyogo, Japan, 14Osaka Police Hospital, Department of Gastroenterology, 10–31, Kitayama-cho, Tennoji-ku, Osaka, Japan, 15Osaka Minami Medical Centre, National Hospital Organisation, Department of Gastroenterology, 2-1, Kidohigashimachi, Kawachinagano, Osaka, Japan, 16Graduate School of Medicine and Faculty of Medicine, Kyoto University, Department of Clinical Oncology, Pharmacogenomics, and Palliative Medicine, Kyoto, Japan
P680
Aetiological risk factors for developing paediatric inflammatory bowel disease in a prospective cohort
I. Yu*1, E. O’Neill1, R. Stanley1, A. Carey2, 3, S. Kiernan2, M. Hamzawi2, K. Driscoll2, S. Quinn2, A. M. Broderick1, 2, B. Bourke1, 2, 3, T. Rafferty2, 3, S. Hussey1, 2, 3
1University College Dublin, Academic Centre for Paediatric Research, School of Medicine and Medical Science, Dublin, Ireland, 2Our Lady’s Hospital for Sick Children Crumlin, Department of Gastroenterology & Hepatology, Dublin, Ireland, 3Our Lady’s Hospital for Sick Children Crumlin, National Children’s Research Centre, Dublin, Ireland
P681
Long-term outcomes of a cohort of Crohn’s disease patients with idiopathic lymphopenia
V. Roales1, C. Alba1, J. L. Mendoza1, D. Olivares1, E. Rey2, C. Taxonera*1
1Hospital Clinico San Carlos, IBD Unit, Madrid, Spain, 2Hospital Clinico San Carlos, Gastroenterology, IdiSSC, Madrid, Spain
P682
Clinical characteristics of Crohn’s disease or ulcerative colitis patients who initiated vedolizumab or an anti-TNF-α as first biologic therapy
H. Liang1, S. Manne1, J. Shick1, S. Yu1, G. Fusco1, P. Dolin*2
1Takeda Development Centre Americas, Inc., Deerfield, United States, 2Takeda Development Centre Europe Ltd., London, United Kingdom
P683
Skin lesions in patients with inflammatory bowel disease from southern Brazil: an epidemiologic study
H. Amarante*1, G. Reis1, A. Szczypkovski1, G. Quadros1, M. Peretti2, M. Mukai2
1Hospital de Clínicas of Federal University of Parana, Gastroenterology, Curitiba, Brazil, 2Hospital de Clínicas of Federal University of Parana, Dermatology, Curitiba, Brazil
P684
A shift to outpatient expenditures in healthcare costs for inflammatory bowel disease: a population-based study in Korea (2010–2014)
C. K. Lee*1, S. Y. Rhee1, H. J. Kim1, S. J. Oh1, C. H. Oh1, W.-M. Lim2
1Kyung Hee University School of Medicine, Internal Medicine, Seoul, South Korea, 2Janssen Korea, Seoul, South Korea
P685
Vitamin D levels in newly diagnosed UC are lower in South Asians than white Europeans: Could this be contributing to the increasing incidence of UC in South Asians?
R. Misra*1, U. Selvarajah2, O. Faiz3, J. Burisch4, P. Munkholm4, N. Arebi5
1St Marks Academic Institute, Gastroenterology, London, United Kingdom, 2Imperial College NHS Healthcare Trust, Gastroenterology, London, United Kingdom, 3St Mark’s Academic Institute, Colorectal Surgery & IBD Unit, London, United Kingdom, 4North Zealand University Hospital, Gastroenterology, Frederikssun, Denmark, 5St Marks Academic Institute, Gastroenterology, London, United Kingdom
P686
Characteristics of small bowel cancer associated with Crohn’s disease
M. Shinozaki*
The Institute of Medical Science, The University of Tokyo, Department of Surgery, Tokyo, Japan
P687
The effect of inflammatory bowel disease on patients’ caregivers
A. Zand*, A. Platt, W. K. Van Deen, D. W. Hommes
UCLA Centre for Inflammatory Bowel Diseases, Division of Digestive Diseases, Los Angeles, California, United States
P688
Is smoking cessation linked to new ulcerative colitis cases?—A retrospective cohort based hypothesis
M. Grueber*1, N. Fournier2, L. Biedermann3, S. Vavricka4, A. Schöpfer5, C. Clair Willi6, M. Allez7, A. J. Macpherson8, P. Juillerat9
1Inselspital, Bern, Department of Gastroenterology, Bern, Switzerland, 2CHUV, Statistics, Lausanne, Switzerland, 3Universitätsspital, Gastroenterology, Zürich, Switzerland, 4Stadtspital Triemli, Gastroenterology, Zürich, Switzerland, 5CHUV, Gastroenterology, Lausanne, Switzerland, 6CHUV, PMU, Lausanne, Switzerland, 7Hôpital Saint-Louis, Gastroenterology, Lausanne, France, 8Inselpital, Gastroenterology, Bern, Switzerland, 9Inselspital, Gastroenterology, Bern, Switzerland
P689
An observational study on Crohn’s disease activity pattern and long-term outcomes of management strategies in the routine clinical setting in Greece
G. Paspatis*1, S. Potamianos2, K. Triantafyllou3, C. Tzathas4, G. Theocharis5, S. Michopoulos6, E. Akriviadis7, J. Karagiannis8, G. Alexopoulou9, A. Boubougianni9, A. Kouloumenta9, S. Ladas10
1Department of Gastroenterology, Benizelion General Hospital, Heraklion, Greece, 2Department of Gastroenterology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece, 3Hepatogastroenterology Unit, Second Department of Internal Medicine and Research Institute, Attikon University General Hospital, Medical School, Athens, Greece, 4Gastroenterology Department, Tzaneion General Hospital, Piraeus, Greece, 5Department of Gastroenterology, University Hospital of Patras, Rio/Patra, Greece, 6Department of Gastroenterology, Alexandra University Hospital, Athens, Greece, 7Department of Internal Medicine, General Hospital of Thessaloniki, Hippokratio, Thessaloniki, Greece, 8Gastroenterology Unit, Konstantopoulio Hospital, Athens, Greece, 9MSD, Athens, Greece, 10Department of Medicine & Gastroenterology, Medical School, ‘Laiko’ University General Hospital of Athens, University of Athens, Athens, Greece
P690
Worries of patients with inflammatory bowel disease: an indicator of well-being?—results of survey amongst 1 096 participants in a European bilingual clinical cohort
V. Pittet*1, C. Vaucher1, F. Froehlich2, B. Burnand1, P. Michetti3, M. H. Maillard4
1Institute of Social and Preventive Medicine, Healthcare Evaluation Unit, Lausanne, Switzerland, 2University Hospital Basel, Division of Gastroenterology & Hepatology, Basel, Switzerland, 3Clinique La Source-Beaulieu, Crohn and Colitis Centre, Lausanne, Switzerland, 4Lausanne University Hospital, Department of Gastroenterology & Hepatology, Lausanne, Switzerland